PEStore

Venture Capital

NEXT VENTŪRES

NEXT VENTŪRES backs early-stage and high-growth companies, typically pre-profit, from Austin, TX. It states a focus on healthcare & life sciences.

Disclosed holdings29
Earliest stated investment
HeadquartersAustin, TX
Largest single fundNot stated

Stated investment criteria

What NEXT VENTŪRES says it buys

Read from NEXT VENTŪRES’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Founded20191

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Nothing here is a commitment by NEXT VENTŪRES to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How NEXT VENTŪRES is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised5 · $185m gross
SEC adviser numberCRD 309808

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies NEXT VENTŪRES lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
BranchLab
Cofertility
Eatevergreen
Ephemeral
Ephemeral Technologies
Eternal
Genopets
Hammerhead
Healthier
Healthier Intelligence
Juno
Livemomentous
Moodhealth
Okcapsule
Oura Ring
Outside
Outsideinc
Pair Team
Powerdot
Prosefoods
Ramble
Scorchedice
Steadymd
Tokaido Health
Trial Library
Tryterra
Vital Biosciences
Vitalbio
Wthn

Compiled from NEXT VENTŪRES’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this NEXT VENTŪRES?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.